CVS Health (NYSE: CVS) reported Q4 EPS of $1.98, $0.37 better than the analyst estimate of $1.61. Revenue for the quarter came in at $76 billion versus the consensus estimate of $74.89 billion.

GUIDANCE:

CVS Health sees FY2022 EPS of $8.10-$8.30, versus the consensus of $8.28.

For earnings history and earnings-related data on CVS Health (CVS) click here.